Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-24T06:34:31.900Z Has data issue: false hasContentIssue false
  • English
  • Français

Progression and Outcome of Patients in a Canadian Dementia Clinic

Published online by Cambridge University Press:  18 September 2015

David B. Hogan ,
Daniel E. Thierer ,
Erika M. Ebly  and
Irma M. Parhad
David B. Hogan*
Affiliation:
Departments of Medicine. Clinical Ncurosciences and Pathology. University of Calgary, Calgary
Daniel E. Thierer
Affiliation:
Departments of Medicine. Clinical Ncurosciences and Pathology. University of Calgary, Calgary
Erika M. Ebly
Affiliation:
Departments of Medicine. Clinical Ncurosciences and Pathology. University of Calgary, Calgary
Irma M. Parhad
Affiliation:
Departments of Medicine. Clinical Ncurosciences and Pathology. University of Calgary, Calgary
*
University of Calgary, Health Sciences Centre, 3330 Hospital Drive N.W.. Calgary, Alberta. Canada T2N 4NI
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Five hundred and fifty-three patients were referred to a Canadian dementia clinic for standardized evaluation. The majority (83.5%) had a dementia with Alzheimer’s disease (AD) accounting for 89% of dementias. Patients with probable AD who were followed for five years had variable rates of progression, increased mortality (37.1%, 2.5 times the expected rate) and a high rate of institutionalization (79%). Simple demographic (age) and social factors (marital status) were strong predictors for institutionalization. It was extremely difficult at presentation to predict the rate of progression. The prevalence of AD in autopsied cases was 62.5%. Clinic patients were younger, had milder dementias, and were more likely to have AD than patients identified in the course of a contemporaneous population-based dementia prevalence study.

Résumé:

Résumé:

Progression et devenir des patients référés dans une clinique canadienne de démence. Cinq cent cinquante-trois patients ont été référés à une clinique canadienne de démence pour subir une évaluation standardisée. La majorité (83.5%) avaient une démence et 89% des démences étaient dues à la maladie d’Alzheimer. Les patients avec maladie d’Alheimer probable, qui ont été suivis pendant cinq ans, avaient des taux variables de progression, une mortalité plus élevée (37.1%, soit 2.5 fois le taux attendu) et un taux élevé d’institutionnalisation (79%). Des facteurs démographiques (l’âge) et sociaux (l’état matrimonial) simples étaient des prédicteurs puissants de l’institutionnalisation. Il était extrêmement difficile à l’évaluation initiale de prédire le taux de progression. La prévalence de la maladie d’Alzheimer chez les cas ayant subi une autopsie était de 62.5%. Les patients de la clinique étaient plus jeunes, avaient une démence moins sévère et étaient plus susceptibles d’avoir la maladie d’Alzheimer que les patients identifiés lors d’une étude de population concomitante étudiant la prévalence de la démence.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 21 , Issue 4 , November 1994 , pp. 331 - 338
Copyright
Copyright © Canadian Neurological Sciences Federation 1994

References

REFERENCES

1. Verhey, FR, Jolles, J, Ponds, RW, et al. Diagnosing dementia- a comparison between a monodisciplinary and a multidisiciplinary approach. J Neuropsychiatry Clin Neurosci 1993; 5: 78–85.Google Scholar
2. Thai, LJ, Grundman, M, Klauber, MR. Dementia: Characteristics of a referral population and factors associated with progression. Neurology 1988; 38: 1083–1090.Google Scholar
3. Erkinjuntti, T, Sulkava, R, Kovanen, J, Palo, J. Suspected dementia: evaluation of 323 consecutive referrals. Acta Neurol Scand 1987; 76: 359–364.Google Scholar
4. Brodaty, H. Low diagnostic yield in a memory disorders clinic. Int Psychogeriatr 1990; 2: 149–159.Google Scholar
5. Larson, EB, Reifler, BV, Featherstone, HJ, English, DR. Dementia in elderly outpatients: a prospective study. Ann Intern Med 1984; 100:417–423.Google Scholar
6. Van der Cammen, TJM, Simpson, JM, Fraser, RM, Preker, AS, Exton-Smith, AN. The Memory Clinic: a new approach to the detection of dementia. Br J Psychiatry 1987; 150: 359–364.CrossRefGoogle Scholar
7. Bayer, AJ, Pathy, MSJ, Twining, C. The Memory Clinic: a new approach to the detection of early dementia. Drugs 1987; 33: 84–89.CrossRefGoogle Scholar
8. Reding, MJ, Haycox, J, Wigforss, K, Brush, D, Blass, JP. Follow up of patients referred to a dementia service. J Am Geriatr Soc 1984; 32: 265–268.Google Scholar
9. Brayne, C. Clinicopathological studies of the dementias from an epidemiological viewpoint. Br J Psychiatry 1993; 162: 439–446.Google Scholar
10. Galasko, D, Corey-Bloom, J, Thai, LJ. Monitoring progression in Alzheimer’s disease. J Am Geriatr Soc 1991; 39: 932–941.CrossRefGoogle ScholarPubMed
11. Morris, JC, Edland, S, Clark, C, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) – Part IV: Rates of cognitive change in the longitudinal assessment of probable AD. Neurology 1993; 43: 2457–2465.Google Scholar
12. Brooks, JO, Kraemer, HC, Tanke, ED, Yeasavage, JA. The methodology of studying decline in Alzheimer’s disease. J Am Geriatr Soc 1993; 41:623–628.Google Scholar
13. Mayeux, R, Stern, Y, Spanton, S. Heterogeneity in dementia of the Alzheimer’s type: evidence of subgroups. Neurology 1985; 35: 453–461.Google Scholar
14. Mortimer, JA, Ebbitt, B, Jun, SP, Finch, MD. Predictors of cognitive and functional progression in patients with Probable Alzheimer’s disease. Neurology 1992; 42: 1689–1696.CrossRefGoogle ScholarPubMed
15. Burns, A, Levy, R. Clinical diversity in late onset alzheimer’s Disease. Oxford: Oxford University Press, 1992.Google Scholar
16. Forstl, H, Resthom, C, Geiger-Kabisch, C, et al. Psychotic features and the course of Alzheimer’s disease-relationship to cognitive, electroencephalographic and computerized tomography findings. Acta Psychiatr Scand 1993; 87: 395–399.Google Scholar
17. Kuskowski, MA, Mortimer, JA, Morley, GK, et al. Rate of cognitive decline in Alzheimer’s disease is associated with alpha EEG power. Biol Psychiatry 1993; 33: 659–662.Google Scholar
18. Stern, Y, Folstein, M, Albert, M, et al. Multicenter study of predictors of disease course in Alzheimer’s disease (the “predictors study”) I: Study design, cohort description and intersite comparison. Alzheimer Dis Assoc Disord 1993; 7(1): 3–21.CrossRefGoogle Scholar
19. Richards, M, Folstein, M, Albert, M, et al. Multicenter study of predictors of disease course in Alzheimer’s disease (the “predictors study”). II: Neurological, psychiatric and demographic influences on baseline measurements of disease severity. Alzheimer Dis Assoc Disord 1993; 7(1): 22–32.Google Scholar
20. Yesavage, JA, Brooks, JO, Taylor, J, Tinklenburg, J. Development of aphasia, apraxia, and agnosia and decline in Alzheimer’s disease. Am J Psychiatry 1993; 150: 742–747.Google Scholar
21. Lucca, U, Comelli, M, Tettamanti, M, et al. Rate of progression and prognostic factors in Alzheimer’s disease – a prospective study. J Am Geriatr Soc 1993; 41: 45–49.Google Scholar
22. Mann, UM, Mohr, E, Gearing, M, Chase, TN. Heterogeneity in Alzheimer’s disease-progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. J Neurol Neurosurg Psychiatry 1993; 55: 956–959.CrossRefGoogle Scholar
23. Tombaugh, TN, Mclntyre, NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40(9): 922–935.Google Scholar
24. Barclay, LL, Zemcov, A, Blass, JP, McDowell, FH. Factors associated with duration of survival in Alzheimer’s disease. Biol Psychiatry 1985; 20:86–93.Google Scholar
25. Barclay, LL, Zemcov, A, Blass, JP, Sansone, J. Survival in Alzheimer’s disease and vascular dementias. Neurology 1985; 35: 834–840.CrossRefGoogle ScholarPubMed
26. Diesfeldt, HFA, van Houte, LR, Moerkens, RM. Duration of survival in senile dementia. Acta Psychiatr Scand 1986; 73: 366–371.Google Scholar
27. Mölsä, PK, Marttila, RJ, Rinne, UK. Survival and cause of death in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 1986; 74: 103–107.CrossRefGoogle ScholarPubMed
28. Martin, DC, Miller, JK, Kapoor, W, Arena, VC, Boiler, F. A controlled study of survival with dementia. Arch Neurol 1987; 44: 1122–1126.Google Scholar
29. Hier, DB, Warach, JD, Gorelick, PB, Thomas, J. Predictors of survival in clinically diagnosed Alzheimer’s disease and multi-infarct dementia. Arch Neurol 1989; 46: 1213–1216.CrossRefGoogle ScholarPubMed
30. Robinson, JR. The natural history of mental disorder in old age: a long-term study. Br J Psychiatry 1989; 154: 783–789.Google Scholar
31. Walsh, JS, Welch, GH, Larson, EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 1990; 113: 429–434.Google Scholar
32. Kazniak, AW. Fox, J, Gandell, DL, et al. Predictors of mortality in presenile and senile dementia. Ann Neurol 1978; 3: 246–252.Google Scholar
33. Volicer, BJ, Hurley, A, Fabiszewski, KJ, et al. Predicting short-term survival for patients with advanced Alzheimer’s disease. J Am Geriatr Soc 1993; 41: 535–540.Google Scholar
34. Drachman, DA, O’Donnell, BF, Lew, RA, Swearer, JM. The prognosis in Alzheimer’s disease. Arch Neurol 1990; 47: 851–856.CrossRefGoogle ScholarPubMed
35. Brodaty, H, McGilchrist, C, Harris, L, Peters, KE. Time until institutionalization and death in patients with dementia. Arch Neurol 1993; 50: 643–650.Google Scholar
36. Canadian Study of Health and Aging. The Canadian study of health and aging: study methods and prevalence of dementia. Can Med Assoc J 1994; 150:899–913.Google Scholar
37. Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.CrossRefGoogle ScholarPubMed
38. Blessed, GL, Tomlinson, BE, Roth, M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797–811.Google Scholar
39. Morris, JC, Heyman, A, Mohs, RC, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I: Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989; 39: 1159–1165.Google Scholar
40. Hachinski, VC, Iliff, LD, Zilhka, E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 8: 141–151.Google Scholar
41. Hendrie, HC, Hall, KS, Brittain, HM, et al. The CAMDEX. J Am Geriatr Soc 1988; 36: 402–408.Google Scholar
42. Morris, JC, Mohs, RC, Roger, H, Fillenbaum, G, Heyman, A. Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) Clinical and Neuropsychological Assessment of Alzheimer’s Disease. Psychopharmacol Bull 1988; 24: 641–644.Google Scholar
43. LeMay, M, Stafford, JL, Sandor, T, et al. Statistical assessment of perceptual CT scan rating inpatients with Alzheimer type dementia. J Comput Assist Tomogr 1986; 10: 802–809.CrossRefGoogle Scholar
44. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980.Google Scholar
45. Diagnostic and statistical manual of mental disorders (revised). 3rd ed. Washington; DC: American Psychiatric Association, 1987.Google Scholar
46. McKhann, G, Drachman, D, Folstein, M, et al. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer’s disease. Neurology 1984; 34: 939–944.Google Scholar
47. Life tables, Canada and Provinces 1985–1987. Statistics Canada Health Reports, 1990:49.Google Scholar
48. Teng, EL. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatr 1987; 48:314–318.Google ScholarPubMed
49. Canadian Study of Health and Aging, personal communication.Google Scholar
50. Larson, EB, Reifler, BV, Sumi, SM. Diagnostic tests in the evaluation of dementia. Arch Intern Med 1986; 146: 1917–1922.Google Scholar
51. Roman, GG, Tatemichi, TK, Erkinjuntti, T, et al. Vascular dementia: diagnostic criteria for research studies. Neurology 1993; 43: 250–260.Google Scholar
52. Boiler, F, Lopez, OL, Moossy, J. Diagnosis of dementia: clinicopathologic correlations. Neurology 1989; 39: 76–79.CrossRefGoogle Scholar
53. Sulkava, R, Haltia, M, Paetau, A, Wikstrom, J, Palo, J. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 1983; 46:9–13.Google Scholar
54. Mölsä, PK, Paljärvi, L, Rinne, JO, Rinne, UK, Säkö, E. Validity of clinical diagnosis in dementia: a prospective clinicopathological study. J Neurol Neurosurg Psychiatry 1985; 48: 1085–1090.Google Scholar
55. Wade, JP, Mirsen, TR, Hachinski, VC, et al. The clinical diagnosis of Alzheimer’s disease. Arch Neurol 1987; 44: 24–29.Google Scholar
56. Homer, AC, Honavar, M, Lantos, PL, et al. Diagnosing dementia: do we get it right? Br Med J 1988; 297: 894–896.Google Scholar
57. Risse, SC, Raskind, MA, Nochlin, D, et al. Neuropathological findings in patients with clinical diagnosis of Probable Alzheimer’s Disease. Am J Psychiatry 1990; 147: 168–172.Google ScholarPubMed
58. Thai, L, Galasko, D, Katzman, R, et al. Patients clinically assessed at an Alzheimer’s center generally have Alzheimer’s pathology. Neurology 1991; 41: 323.(Abstract)Google Scholar
59. Burns, A, Luthert, P, Levy, R, Jacoby, R, Lantos, P. Accuracy of clinical diagnosis of Alzheimer’s disease. Br Med J 1990; 301: 1026.Google Scholar
60. Gilleard, CJ, Kellet, JM, Coles, JA, et al. The St. George’s dementia bed investigation study: a comparison of clinical and pathological diagnosis. Acta Psychiatr Scand 1992; 85: 264–269.CrossRefGoogle Scholar
61. Boiler, F, Becker, JT, Holland, AL, et al. Predictors of decline in Alzheimer’s disease. Cortex 1991; 27: 9–17.Google Scholar
62. Huff, FJ, Belle, SH, Shim, YK, Ganguli, M, Boiler, F. Prevalence and prognostic value of neurologic abnormalities in Alzheimer’s disease. Dementia 1990; 1: 32–40.Google Scholar